Summary
ENOV Chart
What Makes Enovis (ENOV) a New Buy Stock
Enovis (ENOV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Enovis (ENOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Enovis Targets Robotic Surgery Expansion With €155M eCential Robotics Deal
Enovis NYSE: ENOV said it has entered a binding offer to acquire eCential Robotics, a developer of surgical robotics technology, in a move the orthopedic company said will expand its enabling-technology capabilities and accelerate its pathway into robotic surgery.
Enovis Corporation Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 141 | $3,414.6 | $2,616.96 | -$797.64 | -23.36% |
| ABB Alexander Bjornager Bonde Danske Bank A/S | 200 | $5,328 | $3,712 | -$1,616 | -30.33% |
 Mason Hawkins Southeastern Asset Management | 44,258 | $1.81M | $843,991.21 | -$961,661.68 | -53.26% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 16 | $364 | $296.96 | -$67.04 | -18.42% |
| BG Bart Gancher Intech Investment Management LLC | 12,268 | $359,831.27 | $326,390.14 | -$33,441.13 | -9.29% |
Enovis Corporation Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Danielle Antalffy UBS | 1,553.69 | $45,864.81 | $28,836.41 | -$17,028.4 | -37.13% |
 Larry Biegelsen Wells Fargo | 8,046.62 | $214,080.23 | $149,345.2 | -$64,735.03 | -30.24% |
Enovis Corporation (ENOV) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Enovis Corporation ever had a stock split?
Enovis Corporation Profile
| Machinery Industry | Industrials Sector | Damien McDonald CEO | NYSE Exchange | 194014502 CUSIP |
| US Country | 7,802 Employees | - Last Dividend | 5 Apr 2022 Last Split | - IPO Date |
Overview
Enovis Corporation, a notable entity in the medical technology landscape, operates on a global scale. It specializes in the development, manufacture, and distribution of a varied portfolio of medical device products. These products are designed to cater to the needs of orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and a broad spectrum of other healthcare professionals. The primary focus of the company is to provide solutions for patients suffering from musculoskeletal conditions that arise due to degenerative diseases, deformities, traumatic events, and sports-related injuries. Initially known as Colfax Corporation, Enovis Corporation has rooted its headquarters in Wilmington, Delaware, illustrating a significant presence in the medical technology domain.
Products and Services
Enovis Corporation delivers an extensive array of products and services across the medical technology field:
- Rigid and Soft Orthopedic Bracings: These are designed to support and immobilize various parts of the body to assist with the healing process of musculoskeletal issues.
- Hot and Cold Therapy Products: Utilized for pain relief and reducing inflammation, these therapy products play a crucial role in both acute and chronic injury management.
- Bone Growth Stimulators: Aimed at enhancing the healing process of bones, these devices are especially beneficial for patients experiencing slow healing in fractures and other bone-related conditions.
- Vascular Therapy Systems and Compression Garments: These products are intended to improve blood circulation, reduce swelling, and enhance the recovery process in patients with vascular issues or those recovering from surgery.
- Therapeutic Shoes and Inserts: Designed for individuals suffering from foot-related conditions, these products help in reducing pain and enhancing mobility.
- Electrical Stimulators for Pain Management: These devices are used in the treatment of pain, employing electrical stimulation to relieve chronic and acute musculoskeletal pain.
- Physical Therapy Products: A broad range of products supporting physical therapy practices, including exercise equipment and tools for rehabilitation and strengthening.
- Reconstructive Joint Products: Offering a suite of products for the hip, knee, shoulder, elbow, foot, ankle, and fingers, these items are integral for joint reconstruction surgeries and treatments.
Moreover, Enovis Corporation markets its cutting-edge products through a combination of independent distributors, including healthcare professionals, consumer retail stores, and pharmacies, and directly to consumers under the notable DJO brand. This strategic approach allows the company to span a wide market, reaching various healthcare providers and patients efficiently.
